Long-term Outcome of RIPC After IV Thrombolysis in AIS Patients (RESPONTH)

Xi'an Jiaotong University

Status: Completed

Conditions: Acute Ischemic Stroke

Treatments: Other: functional and medical information

Study type: Observational

Funder types: Other

Identifiers

NCT05614401

XJTU1AF2022LSK-407

Details and patient eligibility

About

The goal of this observational study is to learn about the long-term efficacy of our previous study in acute ischemic stroke(AIS) patients who underwent either remote ischemic postconditioning(RIPC) or sham treatment after intravenous thrombolysis. The main questions it aims to answer are:

• Dose the RIPC treatment combined with IV thrombolysis can improve the long-term functional outcome in AIS patients?
• Dose the RIPC treatment combined with IV thrombolysis can improve the incidence rates of all-cause and cardiovascular mortality, recurrent stroke/TIA, new-onset clinical AF on this long-term follow-up? A single rater (A.E.P.) trained by an experienced stroke physician (S.T.E.) contacted patients, relatives, and family physicians to gather all available medical information on the following issues: 1) survival status, 2) date of death in those who died (based on information of the treating physicians), 3) mRS score at the time of the interview, 4) recurrent stroke/TIA, 5) new onset atrial fibrillation, 6) other cardiovascular events, including myocardial infarction, pulmonary embolism, deep venous thrombosis, peripheral arteriopathy.

Researchers will compare RIPC group and control group to see if the RIPC treatment have a long-term effect in AIS patients.

Enrollment: 62 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• All patients who completed the previous interventional rater-blinded controlled study were invited for the follow-up session.

Trial design

62 participants in 2 patient groups

RIPC group

Description:

Patients underwent RIPC treatment after IV thrombolysis in the index stroke.

Treatment:

Other: functional and medical information

Control group

Description:

The control group underwent no inflations or deflations in the index stroke.

Treatment:

Other: functional and medical information